Giacomelli, Andrea <br/><br/>
Factors involved in continuance of atazanavir-based regimens: Results from a cohort of HIV1-positive patients.  [electronic resource] 

 -  Antiviral research  May 2016 
 - 52-57 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1872-9096 
<br/><br/><label>Standard No.: </label>10.1016/j.antiviral.2016.02.010  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Anti-HIV Agents--adverse effects<br/>Antiretroviral Therapy, Highly Active--adverse effects<br/>Atazanavir Sulfate--adverse effects<br/>Bilirubin--blood<br/>Drug Administration Schedule<br/>Female<br/>HIV Infections--drug therapy<br/>HIV Protease Inhibitors--adverse effects<br/>HIV-1--drug effects<br/>Humans<br/>Male<br/>Middle Aged<br/>RNA, Viral--blood<br/>Retrospective Studies<br/>Ritonavir--adverse effects<br/>Treatment Failure<br/>Viral Load